Articles |
From the Department of Geriatrics (K.K., M.A., M.E., M.Y., K.T., S.I., M.I., M.H., H.O., Y.O.) and the Third Department of Internal Medicine (N.Y.), Faculty of Medicine, and the Department of Molecular Biology and Medicine, Research Center for Advanced Science and Technology (T.K.), University of Tokyo, Tokyo, Japan.
Correspondence to Yasuyoshi Ouchi, MD, Department of Geriatrics, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113, Japan.
Abstract Macrophage (M
) foam cell formation is a
characteristic event that occurs in the early stage of
atherosclerosis. To examine the roles of activin-A, a
member of the transforming growth factor-ß superfamily, and
follistatin, the binding protein for activin-A, in M
function, we
investigated their effects on foam cell formation of THP-1 M
s. When
THP-1 M
s were treated with activin-A (5 nmol/L), foam cell formation
and cellular cholesteryl ester accumulation were decreased. This
downregulation was paralleled by a reduction in cell association
and degradation of acetylated LDL. The inhibitory
effect of activin-A on cell association and degradation was dose
dependent, and the effect was blocked by concomitant addition of
follistatin. Activin-A (5 nmol/L) also decreased the Bmax for
acetylated LDL and scavenger receptor mRNA expression.
Follistatin showed an effect opposite to that of activin-A and promoted
M
foam cell formation and cellular cholesteryl ester accumulation.
It increased binding, cell association, and degradation of
acetylated LDL and upregulated scavenger receptor mRNA
expression. Because follistatin is the binding protein for activin-A,
follistatin's effect is considered to be mediated by blocking the
inhibitory effect of intrinsic activin-A. These results
indicate that activin-A inhibits and follistatin promotes M
foam
cell formation by regulating scavenger receptor mRNA expression. We
conclude that activin-A and follistatin play important roles in the
process of atherosclerosis by regulating M
foam
cell formation.
Key Words: activin-A follistatin scavenger receptor foam cell formation
This article has been cited by other articles:
![]() |
C. Smith, A. Yndestad, B. Halvorsen, T. Ueland, T. Waehre, K. Otterdal, H. Scholz, K. Endresen, L. Gullestad, S. S. Froland, et al. Potential anti-inflammatory role of activin A in acute coronary syndromes J. Am. Coll. Cardiol., July 21, 2004; 44(2): 369 - 375. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yndestad, T. Ueland, E. Oie, G. Florholmen, B. Halvorsen, H. Attramadal, S. Simonsen, S. S. Froland, L. Gullestad, G. Christensen, et al. Elevated Levels of Activin A in Heart Failure: Potential Role in Myocardial Remodeling Circulation, March 23, 2004; 109(11): 1379 - 1385. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Engelse, J. M. Neele, T. A. E. van Achterberg, B. E. van Aken, R. H. N. van Schaik, H. Pannekoek, and C. J. M. de Vries Human Activin-A Is Expressed in the Atherosclerotic Lesion and Promotes the Contractile Phenotype of Smooth Muscle Cells Circ. Res., November 12, 1999; 85(10): 931 - 939. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |